Evidence map›Paper›PMID 38187057›Full record

ArticleAmerican journal of cancer research2023

Prognostic nomogram for primary splenic lymphoma: a SEER database-based study.

Fan Chen, Hong Long, Jiachun Ding, Jiaqiang Ren, Bolun Qu, Peilong Cao, Zheng Wang, Zheng Wu, Qingyong Ma, Zhenhua Ma

Abstract read
In one paragraph

Article in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fan ChenDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Hong LongDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China Hengyang 421001, Hunan, China.
Jiachun DingDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Jiaqiang RenDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Bolun QuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Peilong CaoDepartment of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Zheng WangDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Zheng WuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Qingyong MaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.
Zhenhua MaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University No. 277, West Yanta Road, Yanta District, Xi'an 710061, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to establish a nomogram model based on the clinicopathological factors affecting the prognosis of patients with primary splenic lymphoma (PSL) to predict the overall survival (OS) and cancer-specific survival (CSS) of patients. A total of 4074 patients diagnosed with PSL were included in this study. Among them, 4052 cases from the SEER (Surveillance, Epidemiology, and End Results) database were randomized into a training set and an internal validation set in a 7:3 ratio. Another 22 patients from the First Affiliated Hospital of Xi'an Jiaotong University were used as an external validation set. The prognostic factors affecting the OS and CSS of patients were analyzed using univariate and multivariate Cox regression models. Survival analysis was performed using Kaplan-Meier (KM) method and compared by Log-rank test. Then, a nomogram model was established to predict OS and CSS. Finally, the model was validated both internally and externally using the concordance index (C-index), receiver operating characteristic curve (ROC), and calibration curve to evaluate its predictive value, and the decision curve analysis (DCA) was conducted to assess its clinical utility. Our results showed that the model displayed a good prediction ability. In the training set, the OS rates at 1, 3, and 5 years were 85.9%, 75.8% and 70.1%, respectively, while the CSS rates at 1, 3, and 5 years were 91.9%, 86.2% and 82.3%, respectively. Predictors in the prediction model of OS included age, sex, marital status, Ann Arbor stage, histology, surgery, chemotherapy and year at diagnosis. On the other hand, predictors in the model of CSS included age, Ann Arbor stage, histology, chemotherapy, and year at diagnosis. Internal and external validation of the nomogram model showed that the C-index for predicting OS was 0.678 (0.662, 0.694) in the training set, 0.672 (0.648, 0.696) in the internal validation set, and 0.704 (0.565, 0.843) in the external validation set; the C-index for predicting CSS was 0.685 (0.661, 0.709) in the training set, 0.683 (0.650, 0.716) in the internal validation set, and 0.676 (0.488, 0.864) in the external validation set. The calibration curves for several groups showed good consistency, and DCA suggested its clinical usability. In conclusion, the nomogram constructed in this study has a good predictive value for the survival of patients with PSL, and can be a clinically applicable and practical prediction tool, facilitating rapid and accurate individualized predictions of the patient survival.

Indexed as

cancer-specific survivalnomogramoverall survivalPrimary splenic lymphoma

Identifiers

PMID38187057
PMCPMC10767346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.